AMLX AMYLYX PHARMACEUTICALS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 14 analyst firms say about AMYLYX PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
14 rated views · 15 analyst/firm records · 14 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8052
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8054
Recent analyst activity · last 90 days
Our tracked history has 9 reports on AMLX from 6 analyst firms in the last 90 days (15 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 3 left it unchanged and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Guggenheim raised its target from $55.00 (set 19 Aug 2026) to $57.00 on 27 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Christopher Chen | Buy | 7 Aug 2026 | 52.00 USD |
| Baird | Joel Beatty | Buy | 19 Aug 2026 | 52.00 USD |
| Citigroup | Geoff Meacham | Buy | 15 Oct 2026 | 39.00 USD |
| Evercore ISI | Michael G Difiore | Hold | 6 Aug 2026 | 20.00 USD |
| Goldman Sachs | Corinne Johnson | Buy | 14 May 2026 | 23.00 USD |
| Guggenheim | Seamus Fernandez | Buy | 27 Aug 2026 | 57.00 USD |
| H.C. Wainwright | Andrew S. Fein | Buy | 18 Aug 2026 | 55.00 USD |
| Leerink Partners | Marc Goodman | Buy | 6 Aug 2026 | 40.00 USD |
| Lifesci Capital | Rami Katkhuda | Buy | 3 Mar 2026 | 24.00 USD |
| Mizuho | Graig Suvannavejh | Buy | 18 Aug 2026 | 42.00 USD |
| Stifel | James Condulis | Buy | 3 Mar 2026 | 21.00 USD |
| TD Cowen | Joseph Thome | Buy | 24 Mar 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 5 Aug 2026 | — |
| Wolfe Research | Rudy Li | Buy | 17 Aug 2026 | 40.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:46 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.